title: A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma.
authors.affiliation: Albert Einstein Cancer Center, Bronx, New York 10461, USA. kaufman@aecom.yu.edu
authors.forename: H L
authors.initials: HL
authors.lastname: Kaufman
authors.forename: W
authors.initials: W
authors.lastname: Conkright
authors.forename: J
authors.initials: J
authors.lastname: Divito
authors.forename: H
authors.initials: H
authors.lastname: Hörig
authors.forename: R
authors.initials: R
authors.lastname: Kaleya
authors.forename: D
authors.initials: D
authors.lastname: Lee
authors.forename: S
authors.initials: S
authors.lastname: Mani
authors.forename: D
authors.initials: D
authors.lastname: Panicali
authors.forename: L
authors.initials: L
authors.lastname: Rajdev
authors.forename: T S
authors.initials: TS
authors.lastname: Ravikumar
authors.forename: S
authors.initials: S
authors.lastname: Wise-Campbell
authors.forename: M J
authors.initials: MJ
authors.lastname: Surhland
mesh_terms: D019496:Cancer Vaccines / Q000627:therapeutic use*; D002985:Clinical Protocols; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008545:Melanoma / Q000556:secondary / Q000628:therapy*
chemical_list: D019496:Cancer Vaccines